2 results
Approved WMORecruitment stopped
The overall objective of this trial is to generate data on the ovarian stimulation profile obtained when Pergoveris® is started either on stimulation day 1 or stimulation day 6 in ART patients between 36 and 40 years of age (both inclusive). A…
Approved WMORecruitment stopped
To evaluate the effects of COS with tamoxifen or letrozole compared to standard COS, on oocytes retrieved.